RETN and metabolic syndrome: Adipocytokines including ADPN, resistin, and LEP have been found to be associated with obesity, insulin resistance, β-cell dysfunction, endothelial dysfunction, dyslipidemia, and inflammation (Filippatos et al., 2013).